Multiplexed electronic counting of scarce protein targets using nucleic acid nanoparticles
使用核酸纳米粒子对稀有蛋白质靶标进行多重电子计数
基本信息
- 批准号:10353490
- 负责人:
- 金额:$ 24.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAntibodiesBindingBinding ProteinsBiologicalBiological AssayBiological MarkersCancer DiagnosticsCharacteristicsClinicalComplexComplex MixturesDNA-Binding ProteinsDetectionDevelopmentDevicesDimensionsDiseaseEarly DiagnosisElementsEmerging Communicable DiseasesEnzyme-Linked Immunosorbent AssayEventFoundationsIncubatedIndividualLaboratoriesLibrariesLifeLiquid substanceLiteratureMeasurementMeasuresMembraneMicroscopicModelingNanostructuresNanotechnologyNucleic AcidsPathogenicityPatient CareProteinsRNA-Binding ProteinsResearchResearch PersonnelResearch ProposalsSamplingShapesSignal TransductionSpecificityStructureTechniquesTechnologyTimeTissuesUniversitiesantibody conjugateaptamerclinical applicationcombinatorialcostcost effectivedesigndimerelectric fieldexperimental studyhigh rewardhigh riskimprovedindividual patientinnovationinstrumentminimally invasivemultiplex detectionnanonanoparticlenanoporenovel strategiesparticlepersonalized medicineportabilityprenatalprotein biomarkersrapid diagnosisresidenceresponsesensor technologysimulationsingle moleculesolid statetechnology developmentvirtual
项目摘要
PROJECT SUMMARY
This interdisciplinary project synergizes the expertise of three research groups for a proof-of-principle
demonstration of a novel approach for accurate and sensitive detection of scarce protein biomarkers. The key
innovative element of the approach is the use of wireframe-like nucleic acid nanoparticles (NANPs) to bind
protein targets with high affinity either directly or by means of auxiliary antibody proteins. Binding of the protein
targets is detected by first incubating the sample with a cocktail of NANPs and then examining them using a
nanopore in a solid-state membrane. Protein detection relies on measurement of the ionic current flowing through
the nanopore: the ionic current and particle dwell time decreases by a characteristic amount when a NANP of a
certain type enters the nanopore. Importantly, by matching the physical dimensions of the NANP to the physical
dimension of the nanopore, we expect to dramatically increase the residence type of the nucleic acid
nanoparticles within the nanopore and thereby achieve ultra-sensitive (sub-picomolar range) detection of the
protein-bound biomarkers. By designing our NANP probes to produce distinct ionic signatures when bound to
their protein targets, we will achieve multiplex detection of several protein species using the same nanopore as
well as combinatorial detection of biomarkers by assembling the NANP probes and protein biomarkers into a
sandwich like structures. The project will be carried out by the Afonin group at UNC Charlotte that will design
NANPs, the Wanunu group at Northeastern University that will perform the nanopore detection experiments, and
the Aksimentiev group that will use an arsenal of modeling techniques to optimize and improve the detection
strategy. Our ultra-sensitive, portable, rapid, and potentially low-cost technology for quantification of protein
levels is expected to find broad use for the analysis of biological samples, eventually offering sensitive, reliable,
and minimally invasive identification of disease-indicative biomarkers that could be important innovations for
early-stage diagnostics of cancer and other diseases.
项目概要
这个跨学科项目整合了三个研究小组的专业知识,以进行原理验证
展示了一种准确、灵敏地检测稀有蛋白质生物标志物的新方法。关键
该方法的创新要素是使用线框状核酸纳米颗粒(NANP)来结合
直接或通过辅助抗体蛋白以高亲和力靶向蛋白质。蛋白质的结合
首先将样品与 NANP 混合物一起孵育,然后使用
固态膜中的纳米孔。蛋白质检测依赖于流过的离子电流的测量
纳米孔:当 NANP 为
某些类型进入纳米孔。重要的是,通过将 NANP 的物理尺寸与物理尺寸相匹配
纳米孔的尺寸,我们期望显着增加核酸的停留类型
纳米孔内的纳米颗粒,从而实现超灵敏(亚皮摩尔范围)的检测
蛋白质结合生物标志物。通过设计我们的 NANP 探针,在结合时产生不同的离子特征
他们的蛋白质目标,我们将使用与
以及通过将 NANP 探针和蛋白质生物标志物组装成一个生物标志物的组合检测
类似三明治的结构。该项目将由北卡罗来纳大学夏洛特分校的 Afonin 小组实施,该小组将设计
NANPs,东北大学的 Wanunu 小组将进行纳米孔检测实验,以及
Aksimentiev 小组将使用一系列建模技术来优化和改进检测
战略。我们的超灵敏、便携式、快速且潜在低成本的蛋白质定量技术
水平预计将广泛用于生物样品分析,最终提供灵敏、可靠、
以及疾病指示生物标志物的微创鉴定,这可能是重要的创新
癌症和其他疾病的早期诊断。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kirill A Afonin其他文献
Kirill A Afonin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kirill A Afonin', 18)}}的其他基金
Multiplexed electronic counting of scarce protein targets using nucleic acid nanoparticles
使用核酸纳米粒子对稀有蛋白质靶标进行多重电子计数
- 批准号:
10611370 - 财政年份:2022
- 资助金额:
$ 24.33万 - 项目类别:
SMART NANPs: new molecular platform for communication with human immune system and modulation of therapeutic responses
SMART NANP:与人体免疫系统通讯和调节治疗反应的新分子平台
- 批准号:
10331771 - 财政年份:2021
- 资助金额:
$ 24.33万 - 项目类别:
Administrative Supplement to SMART NANPs: new molecular platform for communication with human immune system and modulation of therapeutic responses
SMART NANP 的行政补充:用于与人体免疫系统沟通和调节治疗反应的新分子平台
- 批准号:
10798083 - 财政年份:2021
- 资助金额:
$ 24.33万 - 项目类别:
SMART NANPs: new molecular platform for communication with human immune system and modulation of therapeutic responses
SMART NANP:与人体免疫系统通讯和调节治疗反应的新分子平台
- 批准号:
10557793 - 财政年份:2021
- 资助金额:
$ 24.33万 - 项目类别:
Characterization of various multifunctional nucleic acid nanoparticles and understanding their immunotoxicity
各种多功能核酸纳米粒子的表征并了解其免疫毒性
- 批准号:
9384048 - 财政年份:2017
- 资助金额:
$ 24.33万 - 项目类别:
Characterization of various multifunctional nucleic acid nanoparticles and understanding their immunotoxicity
各种多功能核酸纳米粒子的表征并了解其免疫毒性
- 批准号:
10013239 - 财政年份:2017
- 资助金额:
$ 24.33万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于酵母展示与自体持续突变的纳米抗体快速亲和力成熟技术研究
- 批准号:82204046
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
中国年轻女性接种不同剂次国产双价HPV16/18疫苗的特异性抗体亲和力及细胞免疫反应研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于新抗原受体可变域的赭曲霉毒素A竞争物与VHH抗体互作的亲和力调控机制
- 批准号:32102067
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
- 批准号:
10751480 - 财政年份:2024
- 资助金额:
$ 24.33万 - 项目类别:
TNFRSF13B polymorphisms and immunity to transplantation
TNFRSF13B 多态性与移植免疫
- 批准号:
10734879 - 财政年份:2023
- 资助金额:
$ 24.33万 - 项目类别:
Developing a novel disease-targeted anti-angiogenic therapy for CNV
开发针对 CNV 的新型疾病靶向抗血管生成疗法
- 批准号:
10726508 - 财政年份:2023
- 资助金额:
$ 24.33万 - 项目类别:
Growth plate-targeted IGF1 to treat Turner Syndrome
生长板靶向 IGF1 治疗特纳综合征
- 批准号:
10819340 - 财政年份:2023
- 资助金额:
$ 24.33万 - 项目类别:
Antibody-based therapy for fentanyl-related opioid use disorder
基于抗体的芬太尼相关阿片类药物使用障碍治疗
- 批准号:
10831206 - 财政年份:2023
- 资助金额:
$ 24.33万 - 项目类别: